Brand names: Ozempic (diabetes), Wegovy (obesity)
This is because there is not enough safety data to know whether taking a GLP-1 medicine can cause harm to the baby. Similar warnings are present in patient information leaflets
The medication may help reduce physical hunger and sugar cravings, but the coaching and science-backed lessons are there to help with the everyday stuff, like making better food choices, staying consistent, building confidence, and creating a healthier relationship with food and movement
Retatrutide's triple receptor activity produces larger total weight reduction in clinical trials (~24-29% vs ~20-22% for tirzepatide), but the side effect profile is more demanding during titration
Doctors warn that GLP-1s can cause muscle loss in addition to fat loss
The bottom line GLP-1 drugs cause muscle loss, but not uniquely the ratio is similar to dieting or surgery